Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 2 of 4: Calculated dose-response metrics. - Dataset (ID:20269)

Filter results: >>>>
Cell Clinical Subtype Transcriptional Subtype Small Molecule Antibody Perturbagen Target Perturbagen Class Biological Replicate ID Conc Unit GR50 GEC50 GRmax GRinf GR Hill Coefficient GR_AOC GR r2 Nominal Division Rate
HCC38
TNBC
Basal B
5-DFUR
TYMS
TYMS
10578.143
uM
308.37710
997.79880
-0.0975 -0.5173 0.6049 0.2789
0.9834
1.6935
HCC38
TNBC
Basal B
5-DFUR
TYMS
TYMS
11850.143
uM
173.320
240.01390
0.0956 -0.0902 0.5094 0.2951
0.9876
2.1044
HCC38
TNBC
Basal B
5-FU
TYMS
TYMS
7854.017
uM
95.97870
1000.00000
-0.5133 -0.8772 0.4323 0.5201
0.9440
1.3102
HCC38
TNBC
Basal B
5-FU
TYMS
TYMS
9453.017
uM
204.98770
867.09230
-0.5306 -0.7483 0.6344 0.4287
0.9866
1.2279
HCC38
TNBC
Basal B
5-FU
TYMS
TYMS
9469.131
uM
492.70010
1000.00000
-0.6025 -0.6339 1.1567 0.3652
0.9907
1.0627
HCC38
TNBC
Basal B
Afatinib
EGFR/HER2
ErbB
11850.158
uM
2.43840
3.85560
-0.8302 -0.8605 2.1846 0.4535
0.9902
1.9855
HCC38
TNBC
Basal B
AG1024
IGF1R
RTK
7469.066
uM
inf
inf
0.9727 0.9727 0.0000 0.0128
-0.0529
2.0057
HCC38
TNBC
Basal B
AG1024
IGF1R
RTK
10418.066
uM
inf
inf
0.9039 0.9039 0.0000 0.0609
0.4077
1.1532
HCC38
TNBC
Basal B
AG1024
IGF1R
RTK
7468.066
uM
106.34480
711.3920
0.7048 -1.0000 0.5781 0.0720
0.6582
1.3940
HCC38
TNBC
Basal B
AG1478
EGFR
ErbB
9453.019
uM
inf
inf
0.9233 0.9233 0.0000 0.0531
0.3590
1.1486
HCC38
TNBC
Basal B
AG1478
EGFR
ErbB
7854.016
uM
13.49420
13.19450
-0.1917 0.0530 4.9889 0.1947
0.8974
0.9074
HCC38
TNBC
Basal B
AG1478
EGFR
ErbB
9028.016
uM
92.84250
219.73640
0.1700 -1.0000 1.2752 0.0911
0.9647
1.2348
HCC38
TNBC
Basal B
AS-252424
PI3K
PI3K
10578.141
uM
inf
inf
0.7463 0.7463 0.0000 0.1127
0.4612
1.5679
HCC38
TNBC
Basal B
AS-252424
PI3K
PI3K
11850.158
uM
inf
1.29810
0.7689 0.7997 5.0000 0.0680
0.7890
1.9855
HCC38
TNBC
Basal B
Baicalein
Lipoxygenase
Metabolism
7468.073
uM
7.29580
11.06170
-0.5675 -0.5930 1.8791 0.3904
0.9858
1.4124
HCC38
TNBC
Basal B
Baicalein
Lipoxygenase
Metabolism
10418.072
uM
28.61970
33.98370
-0.6797 -0.6803 5.0000 0.1999
0.9948
1.1007
HCC38
TNBC
Basal B
Baicalein
Lipoxygenase
Metabolism
10578.072
uM
39.8090
48.96280
-0.6724 -0.6824 4.1586 0.1476
0.9977
1.6597
HCC38
TNBC
Basal B
Bortezomib
Proteasome
Proteasome
7469.074
uM
0.06193
0.09293
-0.9586 -0.9333 2.5945 1.1124
0.9992
1.9843
HCC38
TNBC
Basal B
Bortezomib
Proteasome
Proteasome
7469.074
uM
0.06193
0.09293
-0.9586 -0.9333 2.5945 1.1124
0.9992
1.9843
HCC38
TNBC
Basal B
Bortezomib
Proteasome
Proteasome
14909.203
uM
0.01538
0.01897
-0.9320 -0.9266 4.9991 1.2416
0.9995
1.3791
HCC38
TNBC
Basal B
Bortezomib
Proteasome
Proteasome
14909.203
uM
0.01538
0.01897
-0.9320 -0.9266 4.9991 1.2416
0.9995
1.3791
HCC38
TNBC
Basal B
Bortezomib
Proteasome
Proteasome
7468.074
uM
0.05152
0.07779
-0.9826 -0.9779 2.6299 1.1803
0.9995
1.5027
HCC38
TNBC
Basal B
Bortezomib
Proteasome
Proteasome
7468.074
uM
0.05152
0.07779
-0.9826 -0.9779 2.6299 1.1803
0.9995
1.5027
HCC38
TNBC
Basal B
Bosutinib
Src
nRTK
11850.145
uM
1.13470
1.59980
-0.7354 -0.7043 2.5590 0.5723
0.9960
2.1492
HCC38
TNBC
Basal B
Bosutinib
Src
nRTK
10578.145
uM
0.79029
1.31180
-0.8086 -0.7766 1.8496 0.6145
0.9976
1.6766